Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 27, 2026 11:59 ET | Source: AGC Biologics, Inc.

AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance

AGC Biologics is the 2026 Fierce Outsourcing Award recipient for Leadership in Regulatory and Quality Compliance.
April 27, 2026 09:30 ET | Source: Siren Biotechnology, Inc.

Siren Biotechnology Publishes Foundational AAV Immuno-Gene Therapy Data and Announces Presentations at ASGCT 2026

Siren Biotechnology Publishes Foundational AAV Immuno-Gene Therapy Data and Announces Presentations at ASGCT 2026
April 27, 2026 07:25 ET | Source: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Receives Positive FDA Feedback Following Second Type C Meeting on ATH434 Phase 3 Program in Multiple System Atrophy

– Alignment reached on chemistry, manufacturing, and control (CMC) elements of ATH434 Phase 3 development program – – Positive feedback supports readiness for Phase 3 initiation with manufacturing...
April 23, 2026 16:05 ET | Source: LeonaBio, Inc.

LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer

Management to be Joined by Two Clinical Leaders in the Breast Cancer Field Expected to Complete Enrollment in Ongoing ELAINE-3 Phase 3 Registrational Study of Lasofoxifene in Metastatic Breast...
April 23, 2026 12:14 ET | Source: PridCor Therapeutics, LLC

PridCor Therapeutics Secures Global Antiviral Portfolio, Establishing Leadership in Treatment of Long COVID and Infection-Associated Chronic Illnesses

PridCor secures global antiviral portfolio with Phase 2b and Phase 3 assets to advance treatments for Long COVID and chronic illness.
April 23, 2026 07:02 ET | Source: Ocugen

Ocugen to Present at April 2026 Investor and Industry Conferences

MALVERN, Pa., April 23, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that...
April 23, 2026 04:30 ET | Source: Custom Market Insights

Global Automated Insulin Delivery System Market Size/Share Worth USD 2684 Million by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Austin, TX, USA, April 23, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Automated Insulin Delivery System Market Size, Trends and Insights By Product...
April 22, 2026 19:54 ET | Source: Exicure, Inc.

Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)

Exicure enters co-development agreement with Adbiotech to advance Burixafor (GPC-100) combination therapies across multiple indications.
April 22, 2026 17:11 ET | Source: kneat.com, inc.

Kneat to Announce 2026 First-Quarter Financial Results May 13, 2026

Kneat will release its financial results for the quarter ended March 31, 2026, after TSX market close on May 13, 2026.
April 22, 2026 08:45 ET | Source: MECART Corporation

MECART publie les résultats clés d’une étude révisée par des pairs sur les impacts environnementaux du cycle de vie des salles blanches

GREENVILLE, S.C., 22 avr. 2026 (GLOBE NEWSWIRE) -- MECART a annoncé aujourd’hui les résultats d’une analyse du cycle de vie (ACV), démontrant que ses systèmes de salles blanches présentent des...